Janne Papma

Dr. Janne Papma is an Associate Professor in the Department of Neurology at Erasmus MC, Faculty of Medicine. Her research is deeply rooted in clinical neuroscience, with a focus on neurodegenerative disorders such as frontotemporal dementia and Alzheimer's disease. She actively contributes to large-scale collaborative studies, including the ABOARD cohort and the YOD-INCLUDED Consortium, aiming to improve understanding and care for dementia patients.

Her research interests span a broad spectrum of topics including frontotemporal dementia, genetics of neurodegeneration, neuroimaging, mild cognitive impairment, and social cognition in dementia. She has a particular interest in the behavioral and neuropsychiatric aspects of dementia, as well as cross-cultural adaptations of neuropsychological assessments. Her work integrates clinical observation with advanced imaging and genetic analysis.

The recent publication trends highlight her leadership in multicenter clinical studies, development of observational protocols for young-onset dementia, and systematic evaluation of neuropsychological tools across cultures. Her work frequently appears in high-impact journals such as Journal of Neurology, Neurosurgery and Psychiatry, Alzheimer's Research and Therapy, and Neuropsychology Review, reflecting her influence in the field of cognitive neurology.

Dr. Papma supervises research, as indicated by her involvement in doctoral theses and research outputs under supervised work. She is a key contributor to national and international dementia research initiatives, including registry development and cross-cultural validation of assessment tools. Her collaborations span multiple institutions and countries, demonstrating strong network integration in dementia research.

Laboratory and team affiliations include participation in the YOD-INCLUDED Consortium and the ABOARD cohort initiative, both focused on comprehensive dementia research and data harmonization. These teams bring together clinicians, neuroscientists, and public health experts to advance early diagnosis and personalized care for dementia patients.